Cargando…

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

BACKGROUND: In Study 19, maintenance monotherapy with olaparib significantly prolonged progression-free survival vs placebo in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer. METHODS: Study 19 was a randomised, placebo-controlled, Phase II trial enrolling 265 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedlander, Michael, Matulonis, Ursula, Gourley, Charlie, du Bois, Andreas, Vergote, Ignace, Rustin, Gordon, Scott, Clare, Meier, Werner, Shapira-Frommer, Ronnie, Safra, Tamar, Matei, Daniela, Shirinkin, Vadim, Selle, Frédéric, Fielding, Anitra, Lowe, Elizabeth S., McMurtry, Emma L., Spencer, Stuart, Rowe, Philip, Mann, Helen, Parry, David, Ledermann, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219499/ https://www.ncbi.nlm.nih.gov/pubmed/30353045 http://dx.doi.org/10.1038/s41416-018-0271-y

Ejemplares similares

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer
por: Ledermann, Jonathan A, et al.
Publicado: (2016)

Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer
por: Rafii, Saeed, et al.
Publicado: (2017)

Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting
por: Dougherty, Brian A., et al.
Publicado: (2017)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019)

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease
por: Bangham, Madeleine, et al.
Publicado: (2016)

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer()
por: Stanske, Mandy, et al.
Publicado: (2018)

Olaparib Monotherapy for BRIP1-Mutated High-Grade Serous Endometrial Cancer
por: Nakamura, Kohei, et al.
Publicado: (2020)

Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients
por: Bartl, Thomas, et al.
Publicado: (2021)

Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma
por: Christinat, Yann, et al.
Publicado: (2023)

Anything for Billy /
por: McMurtry, Larry
Publicado: (1989)

Terms of endearment /
por: McMurtry, Larry
Publicado: (1992)

Windows Communication Foundation 3.5 unleashed
por: McMurtry, Craig
Publicado: (2009)

Windows communication foundation: unleashed
por: McMurtry, Craig
Publicado: (2007)

Marketing For Dummies
por: McMurtry, Jeanette
Publicado: (2017)

Relief for the exhausted post-positivist: New epistemological choices transcend positivism, relativism, and even post-positivism
por: McMurtry, Angus
Publicado: (2020)

Stanford Emerson Chaille: An Address Delivered on the Occasion of the Chaille Jubilee, at New Orleans, May 19, 1908
por: McMurtry, Lewis S.
Publicado: (1908)

The Perfected Treatment of Fibroid Tumors of the Uterus
por: McMurtry, Lewis S.
Publicado: (1904)

Modern Gastrostomy for Stricture of the Esophagus—with Report of a Case
por: McMurtry, Lewis S.
Publicado: (1896)

Vaginal Hysterectomy for Malignant Disease of the Cervix, and Uterine Myoma
por: McMurtry, L. S.
Publicado: (1894)

Unnecessary Operations on Women
por: McMurtry, Lewis S.
Publicado: (1906)

The Surgical and Serum Treatment of Puerperal Sepsis
por: McMurtry, Lewis S.
Publicado: (1907)

The Shock of Intra-Abdominal Operations—Its Etiology, Prophylaxis and Treatment
por: McMurtry, Lewis S.
Publicado: (1902)

William Warren Potter
por: McMurtry, L. S.
Publicado: (1911)

Large Cyst of Kidney—Nephrectomy—Recovery
por: McMurtry, L. S.
Publicado: (1893)

Rupture of the Duedenum from a Blow on the Abdomen
por: McMurtry, Lewis S.
Publicado: (1880)

The Relation of the So-Called Minor Gynecological Operations to Intrapelvic Inflammation
por: McMurtry, L. S.
Publicado: (1892)

A Case of Aneurism of the Aorta Opening into the Trachea
por: McMurtry, L. S.
Publicado: (1874)

Tolerance of Olaparib in a Patient With Unresectable Serous Gynecologic Cancer and End-Stage Renal Disease
por: Goon, Kelsey C, et al.
Publicado: (2023)

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
por: Ruscito, Ilary, et al.
Publicado: (2018)

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer
por: Van Nieuwenhuysen, Els, et al.
Publicado: (2019)

Comparison of lower limb segment forces during running on artificial turf and natural grass
por: McMurtry, Shea, et al.
Publicado: (2019)

The perceived contributions of non-physician team members to residents’ interprofessional education during a critical care rotation
por: Landriault, Angèle, et al.
Publicado: (2021)

Targeted anti-vascular therapies for ovarian cancer: current evidence
por: Hall, M, et al.
Publicado: (2013)

Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial
por: Pujade-Lauraine, Eric, et al.
Publicado: (2023)

Real‐world clinical outcomes of olaparib therapy in Chinese patients with advanced serous ovarian cancer treated in Macau
por: Cao, Yabing, et al.
Publicado: (2019)

Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial
por: Colombo, Nicoletta, et al.
Publicado: (2021)

Teddy and I Get a Check-Up: A Pilot Educational Intervention Teaching Children Coping Strategies for Managing Procedure-Related Pain and Fear
por: Dalley, Jessica S., et al.
Publicado: (2016)

Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
por: Glajzer, Jacek, et al.
Publicado: (2022)

Mutation profiles in circulating cell‐free DNA predict acquired resistance to olaparib in high‐grade serous ovarian carcinoma
por: Hu, Dianxing, et al.
Publicado: (2022)

The Avian Proghrelin System
por: Richards, Mark P., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_98dc27q1odn7bp0tncs4pt4q3s